LEXEO Therapeutics Bolsters Cardiac Gene Therapy Leadership with New Executive Appointment and Formation of Scientific Advisory Board - read this article along with other careers information, tips and advice on BioSpace
LEXEO Therapeutics Announces Positive Initial Data from Ongoing Phase 1/2 Clinical Trial of AAV-based Gene Therapy Candidate LX1001 in Patients with Alzheimer’s Disease - read this article along with other careers information, tips and advice on BioSpace
In Part 2 of this series on Breakthroughs in Alzheimer’s disease research “Pioneering Gene Therapy” contributing editor Malorye Branca interviews R. Nolan Townsend, the CEO of LEXEO Therapeutics, a biotech company founded by gene therapy pioneer Ron Crystal.
LEXEO Therapeutics, a clinical-stage gene therapy company, is partnering with CDMO, Fujifilm Diosynth Biotechnologies (FDB), to support the development and manufacturing of its AAV-mediated gene therapies.
LEXEO Therapeutics Closes $100 Million Series B Financing to Advance Clinical Stage Gene Therapy Pipeline and Enhance Preclinical Footprint forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.